サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：オピオイド薬の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1180711

オピオイド薬の世界市場 - 成長、将来展望、競合分析（2022年～2030年）

Opioid Drugs Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
オピオイド薬の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月12日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界では、何100万人もの人々が急性または慢性の痛みに苦しんでおり、そのため国内の医療費に大きな影響を与え、オピオイド薬市場の成長機会を支えています。また、オピオイド薬市場は、軽度から中等度の痛みに苦しむリスクの高い高齢者人口の増加にも牽引されています。市販のオピオイド薬を購入する傾向と娯楽薬の需要急増が、オピオイド薬市場の成長を後押しすると予測されています。

当レポートでは、世界のオピオイド薬市場について調査し、市場動向、競合情報、セグメント分析、新興動向、技術分析、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポート概要
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界のオピオイド薬市場
  • 世界のオピオイド薬市場：薬剤別（2021年）
  • 世界のオピオイド薬市場：用途別（2021年）
  • 世界のオピオイド薬市場：地域別（2021年）
  • 魅力的な投資提案：地域別（2021年）

第3章 オピオイド薬市場：競合分析

  • 主要なオピオイド薬市場ベンダーの市場ポジショニング
  • オピオイド薬市場ベンダーの採用戦略
  • 主要な業界戦略
  • 階層分析：2021年対2030年

第4章 オピオイド薬市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のオピオイド薬市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 オピオイド薬市場：薬剤別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • モルヒネ
    • メタドン
    • コデイン
    • オキシコドン
    • メペリジン
    • フェンタニル
    • その他

第6章 オピオイド薬市場：用途別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 疼痛管理
    • 鎮咳薬
    • 下痢
    • 麻酔

第7章 北米のオピオイド薬市場（2020年～2030年）

  • 市場概要
  • オピオイド薬市場：薬剤別（2020年～2030年）
  • オピオイド薬市場：用途別（2020年～2030年）
  • オピオイド薬市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合のオピオイド薬市場（2020年～2030年）

  • 市場概要
  • オピオイド薬市場：薬剤別（2020年～2030年）
  • オピオイド薬市場：用途別（2020年～2030年）
  • オピオイド薬市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋のオピオイド薬市場（2020年～2030年）

  • 市場概要
  • オピオイド薬市場：薬剤別（2020年～2030年）
  • オピオイド薬市場：用途別（2020年～2030年）
  • オピオイド薬市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカのオピオイド薬市場（2020年～2030年）

  • 市場概要
  • オピオイド薬市場：薬剤別（2020年～2030年）
  • オピオイド薬市場：用途別（2020年～2030年）
  • オピオイド薬市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカのオピオイド薬市場（2020年～2030年）

  • 市場概要
  • オピオイド薬市場：薬剤別（2020年～2030年）
  • オピオイド薬市場：用途別（2020年～2030年）
  • オピオイド薬市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • Actavis Plc.
  • Boehringer Ingelheim
  • Endo Pharmaceuticals Inc.
  • Egalet
  • Janssen Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc.
  • Purdue Pharma
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
図表

List of Tables

  • TABLE 1 Global Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 2 Global Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 3 North America Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 4 North America Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 5 U.S. Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 6 U.S. Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 7 Canada Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 8 Canada Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 13 UK Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 14 UK Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 15 Germany Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 16 Germany Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 17 Spain Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 18 Spain Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 19 Italy Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 20 Italy Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 21 France Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 22 France Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 25 Asia Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 26 Asia Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 27 China Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 28 China Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 29 Japan Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 30 Japan Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 31 India Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 32 India Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 33 Australia Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 34 Australia Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 35 South Korea Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 36 South Korea Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 37 Latin America Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 38 Latin America Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 39 Brazil Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 40 Brazil Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 41 Mexico Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 42 Mexico Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 47 GCC Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 48 GCC Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 49 Africa Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 50 Africa Opioid Drugs Market By Application, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Opioid Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Opioid Drugs Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Opioid Drugs Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Opioid Drugs Market: Quality Assurance
  • FIG. 5 Global Opioid Drugs Market, By Drug, 2021
  • FIG. 6 Global Opioid Drugs Market, By Application, 2021
  • FIG. 7 Global Opioid Drugs Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Opioid Drugs Market, 2021
  • FIG. 9 Market Positioning of Key Opioid Drugs Market Players, 2021
  • FIG. 10 Global Opioid Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Opioid Drugs Market, By Drug, 2021 Vs 2030, %
  • FIG. 12 Global Opioid Drugs Market, By Application, 2021 Vs 2030, %
  • FIG. 13 U.S. Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 20 France Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 22 China Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 24 India Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Opioid Drugs Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Opioid Drugs Market (US$ Million), 2020 - 2030
目次
Product Code: 137852-08-22

Opioid is a drug class including a broad range of drugs such as morphine, oxycodone, fentanyl, hydrocodone and others with widened applications in pain management. Opioid drugs produce effective results by interacting with opioid receptors present on nerve cells. Globally, millions of people have been suffering from acute or chronic pain, thus having a huge impact on domestic healthcare expenditure and supporting the growth opportunity of opioid drugs market. Significant risk is associated with misuse of opioid drugs; therefore it is recommended to take these drugs with proper dose and in appropriate condition, with physician's prescription.

Global sales of opioid drugs are greatly influenced by epidemiological factors such as high prevalence of cancer and chronic disorder. Opioid drugs market is also being driven by growing elderly-population, who are at high risk to suffer from mild to moderate pain. Trend towards purchasing over-the-counter opioid drugs and surging demand for recreational drugs are predicted to boost the growth of opioid drugs market. Deaths caused from opioid overdose have been escalating in recent years which is an epidemic in the United States. As per the record of the Centers for Disease Control and Prevention (CDC), opioid caused death of more than 33,000 people in the year 2015 and more than half of them caused due to prescribed opioids.

The sharp increasing trend of opioid overdose and addiction have arisen global health concern and hence many initiatives have been taken by governments and healthcare organizations exerting challenge to the growth of opioid drugs market. Market penetrance of non-opioid drugs to circumvent side-effects and risk associated with opioid drugs also hinder the growth opportunity of opioid drugs market.

The global opioid drugs market has been segmented on the basis of drugs type and application type. Opioid drugs are classified into morphine, methadone, codeine, oxycodone, meperidine, fentanyl and others; whereas as per application, the market is categorized into pain management, cough suppressant, anesthesia and diarrhea. This report is comprised of the cross-sectional details of every segment and sub-segment containing data for the base year of 2020 and projected to 2030 with corresponding CAGR calculated from 2022-2030.

The report on global opioid drugs market offers detailed market insights and comprehensive analysis of market dynamics comprising market drivers, restrains and opportunity with future prospects of opioid drugs market to allow industry experts to identify business opportunities and valuable information about prevailing trend of market to take business decision. Competitive landscape analysis of manufacturers with mergers and acquisition activities, major partnerships, collaboration, have been delivered in the study to develop accurate business strategies.

Actavis Plc., Boehringer Ingelheim, Endo Pharmaceuticals Inc., Egalet, Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Pfizer Inc., Purdue Pharma, Sanofi, Sun Pharmaceutical Industries Ltd. are few of the major manufacturers of global opioid drugs market. This research report contains detailed profiling of these players along with brief description and financial information.

Pain management is estimated to be the spearheading segment as a result of effective outcomes of opioid drugs. Opioid drugs play an important role in treating acute or chronic pain. The World Health Organization stated that, 80% of cancer or AIDS patients and around 67% of patients suffering from pulmonary disease and cardiovascular diseases need medical intervention for relieving pain and this high trend drives the opioid drugs market. The opioid codeine is used as 'gold standard' for cough suppression. However, strict FDA regulation on the usage of opioid drugs in pediatric patients has negative impact on the global opioid drugs market. Opioid drugs are effective for treating chronic diarrhea by lengthening time to pass stool from gut, moreover severe side effects of opioid drug in inducing constipation might hinder the demand for opioid drugs. Opioid drugs are largely used as an anesthetic agent especially in cardiovascular surgical procedures and with increasing number of surgical interventions, the market of opioid drugs is expected to witness major growth.

Most commonly used opioid drugs are morphine followed by codeine, which contribute major revenue to the global opioid drugs market. Morphine is enormously used in pain management for treating moderate to severe pain. Rising prevalence of cancer, arthritis, chronic pain and increasing recreational use of morphine are largely driving the global market of opioid drugs; however, the side effects and risks associated with this drug may affect the growth of opioid drugs market. Surging demand for codeine in pain relief and cough suppression fuel the growth of opioid drugs market; nonetheless, strict action against illegal practice of over-the-counter codeine drugs is expected to impact global opioid drugs market over the coming years. Methadone is gaining popularity due to its effective treatment of opioid-addiction by reducing withdrawal symptoms and diminishing cravings thus supporting the market growth. Fentanyl is more potent in terms of treatment of severe pain; the demand of this drug in treating surgical pain and increasing addiction to this drug have driven the global sales of opioids drugs.

Geographically, the global opioid drugs market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America region is predicted to experience the largest growth due to continuous increasing demand for opioid drugs followed by Europe. The National Institutes of Health has reported that in the year 2015 around 50 million Americans were suffering from severe chronic pain. Such high prevalence of acute and chronic pain acts as the major driver of opioid drugs market in North America. According to the American Society of Interventional Pain Physicians (ASIPP), 80% of global opioid drugs are being consumed in the United States; such high consumption rate and the overall increment in retail sales the since last two decades have driven the opioid drugs market in this region. Increasing illicit usage of opioid drugs like heroine fuels the growth of opioid drugs market in terms of commercial aspect. As per the recorded data in the Centers for Disease Control and Prevention (CDC), around 28,000 deaths were caused in 2014 due to opioid overdose in the United States. To fight against this epidemic, several initiatives have been taken by government to prevent opioid overdose and dependence which is expected to affect the overall growth of opioid drugs market. Europe is expected to experience steady growth as a result of lower non-medical usage of opioids than United States, and strict vigilance of opioid abuse.

Furthermore, rapid development in healthcare expenditure and attention to palliative care for therapy is expected to promote the growth of opioid drugs market in Asia Pacific. Booming market of opioids in China is owing to increasing rate of cancer cases and rising surgical interventions.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Opioid Drugs market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Opioid Drugs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug

Morphine

Methadone

Codeine

Oxycodone

Meperidine

Fentanyl

Others

Application

Pain Management

Cough Suppressant

Diarrhea

Anesthesia

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Opioid Drugs market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Opioid Drugs market?

Which is the largest regional market for Opioid Drugs market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Opioid Drugs market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Opioid Drugs market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Opioid Drugs Market
  • 2.2. Global Opioid Drugs Market, By Drug, 2021 (US$ Million)
  • 2.3. Global Opioid Drugs Market, By Application, 2021 (US$ Million)
  • 2.4. Global Opioid Drugs Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Opioid Drugs Market: Competitive Analysis

  • 3.1. Market Positioning of Key Opioid Drugs Market Vendors
  • 3.2. Strategies Adopted by Opioid Drugs Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Opioid Drugs Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Opioid Drugs Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Morphine
    • 5.3.2. Methadone
    • 5.3.3. Codeine
    • 5.3.4. Oxycodone
    • 5.3.5. Meperidine
    • 5.3.6. Fentanyl
    • 5.3.7. Others

6. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Pain Management
    • 6.3.2. Cough Suppressant
    • 6.3.3. Diarrhea
    • 6.3.4. Anesthesia

7. North America Opioid Drugs Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
  • 7.3. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
  • 7.4.Opioid Drugs Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.1.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.2.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.3.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

8. UK and European Union Opioid Drugs Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
  • 8.3. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
  • 8.4.Opioid Drugs Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.1.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.2.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.3.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.4.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.5.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.6.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

9. Asia Pacific Opioid Drugs Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
  • 9.3. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
  • 9.4.Opioid Drugs Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.1.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.2.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.3.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.4.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.5.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.6.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

10. Latin America Opioid Drugs Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
  • 10.3. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
  • 10.4.Opioid Drugs Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.1.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.2.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.3.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

11. Middle East and Africa Opioid Drugs Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
  • 11.3. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
  • 11.4.Opioid Drugs Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.1.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.2.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Opioid Drugs Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.3.1. Opioid Drugs Market: By Application, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Actavis Plc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Boehringer Ingelheim
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Endo Pharmaceuticals Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Egalet
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Janssen Pharmaceuticals, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Mallinckrodt Pharmaceuticals
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Pfizer Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Purdue Pharma
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Sanofi
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Sun Pharmaceutical Industries Ltd.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives